Condition
Thalassemia, Beta clinical trials and research
As of November 12, 2026, Find a Trial lists 4 Thalassemia, Beta clinical trials that are recruiting, at sites in 17 countries (most in China (2), United States (2), Angola (1)). By phase: Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 17Countries
Newest Thalassemia, Beta clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Long-term observation of BHC001 treatment for beta thalassemia | — | Nanning, Guangxi and 1 other locations | Recruiting | Mar 18, 2024 |
| Long-term safety and effectiveness of BRL-101 in transfusion-dependent beta-thalassemia | — | Guangzhou, Guangdong and 6 other locations | Recruiting | Mar 7, 2024 |
| Investigating genetic factors in blood disorders | — | Boston, Massachusetts and 25 other locations | Recruiting | Apr 5, 2023 |
| Immune suppression treatment for sickle cell disease and beta-thalassemia patients receiving stem cell transplants | Phase 2 | Basking Ridge, New Jersey and 5 other locations | Recruiting | Feb 21, 2023 |
All recruiting trials (4)
-
Long-term observation of BHC001 treatment for beta thalassemia
This study looks at the long-term safety and effects of a treatment called BHC001 in people with beta thalassemia who need regular blood transfusions.
-
Long-term safety and effectiveness of BRL-101 in transfusion-dependent beta-thalassemia
This study looks at whether BRL-101 remains safe and effective over the long term for people with transfusion-dependent beta-thalassemia.
-
Investigating genetic factors in blood disorders
This study is trying to find out how genes affect blood disorders like sickle cell disease and thalassemia by looking at the DNA of many people with these conditions.
-
Immune suppression treatment for sickle cell disease and beta-thalassemia patients receiving stem cell transplants
This study is testing if a new immune suppression treatment can help people with sickle cell disease or beta-thalassemia have better outcomes when they receive stem cell transplants.
Related topics
Quick answers
How many Thalassemia, Beta clinical trials are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 17 countries. The most sites are in China (2 trials), United States (2 trials), Angola (1 trial), Argentina (1 trial), Belgium (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.